Market Study Report adds 2018-2024 Global Cell Line Development market report that offers an exhaustive coverage of the industry with brief analysis, data charts, figures, statistics that help take business decisions, company profiles and more.

Selbyville, DE -- (SBWire) -- 12/03/2018 --MarketStudyReport.com present the report on global Cell Line Development Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2024.

U.S. cell line development market valued around USD 1.1 billion in 2017 and estimated to grow considerably during the forecast timeframe. Launch of sophisticated cell line development technologies, well-established healthcare infrastructure and large-scale production of protein therapeutics will drive the U.S. cell line development market during the forecast timeframe.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467705/

Few notable industry players operating in cell line development market are GE Healthcare, Thermo Fisher Scientific, Lonza Group, Sigma-Aldrich Corporation (Merck), Cytovance Biologics, WuXi AppTec, Sartorius, Corning, Selexis, Vista Biologicals, EuBiologics, Paragon Bioservices, Cobra Biologics, Patheon, Samsung Biologics, NAEJA RGM Pharmaceuticals, GVK BIO, Catalent

Advancement in rDNA technology has escalated demand for recombinant cell lines. Moreover, several applications of rDNA technology including production of various biological products such as enzymes, immunobiological, synthetic hormones and various other anti-cancer agents will drive recombinant cell line type segment during the forecast timeframe.

Reagents and media product segment dominated the industry in 2017 owing to high usage of reagents and media in tissue engineering, toxicity testing, research, bioproduction, development of regenerative medicine and others. It forms essential component for cell line development and cell culture procedures will drive industry growth. Non-mammalian source segment is estimated to grow considerably during the forecast period owing to high application in insecticide screening and toxicology study.

Based on application type, the industry is bifurcated into bioproduction, toxicity testing, drug discovery, tissue engineering and research. Tissue engineering segment will witness robust growth rate during the forecast period due to increasing investment in R&D coupled with rising demand for advanced cancer treatment.
Increasing incidences of cancer coupled with growing demand for monoclonal antibodies and vaccines will drive cell line development market. Rising prevalence of cancer has become major healthcare concern globally, hence government and several other organizations are conducting extensive research to reduce disease burden one of such approach includes cancer cell line development.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467705/

High incident rate of cancer, favorable reimbursement for biologics and rising demand for monoclonal antibodies, vaccines and gene therapy will drive France cell line development market over the coming years. Presence of associations such as The French National Cancer Institute (INCa) working towards reducing cancer prevalence will positively impact the industry growth.

More Details on this Report At: https://www.marketstudyreport.com/reports/cell-line-development-market

Related Report:

Global Biotherapeutics Cell Line Development Market Size, Status and Forecast 2025

This report studies the global Biotherapeutics Cell Line Development market, analyzes and researches the Biotherapeutics Cell Line Development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group & More.

https://www.marketstudyreport.com/reports/global-biotherapeutics-cell-line-development-market-size-status-and-forecast-2025/?utm_source=RR-AN

About Market Study Report
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog